Reference record for OID 2.16.840.1.113883.11.21026

Parent
2.16.840.1.113883.11 (valueSets)
Node code
21026
Node names
  • AdverseEventCRSerCrit
  • adverse-event-clinical-research-seriousness-criteria
Numeric OID
2.16.840.1.113883.11.21026
URN notation
urn:oid:2.16.840.1.113883.11.21026
ASN.1 notation

{2 16 840 1 113883 11 21026}

  • {joint-iso-itu-t(2) country(16) us(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-itu-t(2) country(16) us-joint(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-ccitt(2) country(16) us(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-ccitt(2) country(16) us-joint(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
OID-IRI notation
  • /2/16/840/1/113883/11/21026
  • /Country/840/1/113883/11/21026
  • /Joint-ISO-ITU-T/16/840/1/113883/11/21026
Named path variants
  • /joint-iso-itu-t/country/us/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us-joint/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us-joint/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us-joint/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us-joint/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us-joint/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us-joint/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us-joint/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us-joint/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria

Descriptions

AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria — HL7 Terminology

Action criteria usually associated with serious events that pose a threat to a patient's life or functioning. Adverse Events criteria to expand on the seriousness of the adverse event. Typically used in reporting for Clinical Research, post-market surveillance (e.g. Form FDA 3500A MedWatch). The adverse event seriousness criteria value set is based on the ICH E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting guidance (https://database.ich.org/sites/default/files/E2D_Guideline.pdf). For information on ICH see https://admin.ich.org/sites/default/files/inline-files/OID_Information_Paper_1.pdf from the INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE (ICH) document ICH E2B(R3), the Electronic Transmission of Individual Case Safety Reports (ICSRs) Implementation Guide Data Elements and Message Specification, and ICH M8, the Electronic Common Technical Document

Source records

AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria

Status in source: active.

Names: AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria

Technical details
{
  "url": "http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-seriousness-criteria",
  "date": "2023-07-28T19:27:19+00:00",
  "title": "Adverse Event Clinical Research Seriousness Criteria",
  "status": "active",
  "contact": [
    {
      "telecom": [
        {
          "value": "http://hl7.org",
          "system": "url"
        },
        {
          "value": "hq@HL7.org",
          "system": "email"
        }
      ]
    }
  ],
  "version": "1.0.0",
  "copyright": "This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html",
  "publisher": "Health Level Seven International",
  "experimental": false,
  "resource_type": "ValueSet",
  "oid_identifier": {
    "value": "urn:oid:2.16.840.1.113883.11.21026",
    "system": "urn:ietf:rfc:3986"
  }
}

First Registration Authority (inferred from ancestor 2.16.840.1.113883)

W. Ted Klein

Current Registration Authority (inferred from ancestor 2.16.840.1)

Karen Hughes

Siblings (1453)

OIDNameDirect childrenDescendantsDescription
2.16.840.1.113883.11.16144 packageEntityType, PackageEntityType00
2.16.840.1.113883.11.16145 kitEntityType, KitEntityType00
2.16.840.1.113883.11.16147 nonRigidContainerEntityType, NonRigidContainerEntityType00
2.16.840.1.113883.11.16152 rigidContainerEntityType, RigidContainerEntityType00
2.16.840.1.113883.11.16153 multiUseContainerEntityType, MultiUseContainerEntityType00
2.16.840.1.113883.11.16155 bottleEntityType, BottleEntityType00
2.16.840.1.113883.11.16159 plasticBottleEntityType, PlasticBottleEntityType00
2.16.840.1.113883.11.16170 compliancePackageEntityType, CompliancePackageEntityType00
2.16.840.1.113883.11.16171 blisterPackEntityType, BlisterPackEntityType00
2.16.840.1.113883.11.16176 individualPackageEntityType, IndividualPackageEntityType00
2.16.840.1.113883.11.16184 medicationCap, MedicationCap00
2.16.840.1.113883.11.16188 medicalDevice, MedicalDevice00
2.16.840.1.113883.11.16189 administrationMedicalDevice, AdministrationMedicalDevice00
2.16.840.1.113883.11.16191 injectionMedicalDevice, InjectionMedicalDevice00
2.16.840.1.113883.11.16196 inhalerMedicalDevice, InhalerMedicalDevice00
2.16.840.1.113883.11.16200 accessMedicalDevice, AccessMedicalDevice00
2.16.840.1.113883.11.16201 lineAccessMedicalDevice, LineAccessMedicalDevice00
2.16.840.1.113883.11.16205 clinicalDrug, ClinicalDrug00
2.16.840.1.113883.11.16206 manufacturedDrug, ManufacturedDrug00
2.16.840.1.113883.11.16208 actPharmacySupplyType, ActPharmacySupplyType00
2.16.840.1.113883.11.16209 firstFillPharmacySupplyType, FirstFillPharmacySupplyType00
2.16.840.1.113883.11.16215 refillPharmacySupplyType, RefillPharmacySupplyType00
2.16.840.1.113883.11.16220 emergencyPharmacySupplyType, EmergencyPharmacySupplyType00
2.16.840.1.113883.11.16226 observationType, ObservationType00
2.16.840.1.113883.11.16228 observationDiagnosisTypes, ObservationDiagnosisTypes00
2.16.840.1.113883.11.16231 actMonitoringProtocolCode, ActMonitoringProtocolCode00
2.16.840.1.113883.11.16232 controlledSubstanceMonitoringProtocol, ControlledSubstanceMonitoringProtocol00
2.16.840.1.113883.11.16346 parent, Parent00
2.16.840.1.113883.11.16349 grandparent, Grandparent00
2.16.840.1.113883.11.16360 child, Child00
2.16.840.1.113883.11.16368 livingSubjectProductionClass, LivingSubjectProductionClass00
2.16.840.1.113883.11.16460 dentalServiceProviderHIPAA, DentalServiceProviderHIPAA00
2.16.840.1.113883.11.16466 raceAlaskanNativeAleutBristolBay, RaceAlaskanNativeAleutBristolBay00
2.16.840.1.113883.11.16478 contextControl, ContextControl00
2.16.840.1.113883.11.16492 logicalObservationIdentifierNamesAndCodes, LogicalObservationIdentifierNamesAndCodes00
2.16.840.1.113883.11.16493 externallyDefinedActCodes, ExternallyDefinedActCodes00
2.16.840.1.113883.11.16501 clinicalOrganizationRoleType, ClinicalOrganizationRoleType00
2.16.840.1.113883.11.16508 actIncidentCode, ActIncidentCode00
2.16.840.1.113883.11.16515 specimenRoleType, SpecimenRoleType00
2.16.840.1.113883.11.16521 qualitySpecimenRoleType, QualitySpecimenRoleType00
2.16.840.1.113883.11.16530 drugEntity, DrugEntity00
2.16.840.1.113883.11.16535 actProcedureCode, ActProcedureCode00
2.16.840.1.113883.11.16537 actSite, ActSite00
2.16.840.1.113883.11.16538 humanActSite, HumanActSite00
2.16.840.1.113883.11.16539 animalActSite, AnimalActSite00
2.16.840.1.113883.11.16541 procedureMethod, ProcedureMethod00
2.16.840.1.113883.11.16543 participationMode, ParticipationMode00
2.16.840.1.113883.11.16544 participationModeVerbal, ParticipationModeVerbal00
2.16.840.1.113883.11.16549 participationModeWritten, ParticipationModeWritten00
2.16.840.1.113883.11.16554 participationModeElectronicData, ParticipationModeElectronicData00